Akebia Therapeutics Inc (NASDAQ:AKBA)
| 0.30 Delayed Data As of 3:21pm ET |  0.00 / 0.00%Today’s Change | 0.24 Today|||52-Week Range 2.93 | -86.73% Year-to-Date |
Latest AKBA News | Press Releases
No recent news for Akebia Therapeutics Inc.
Today’s Trading
| Previous close | 0.30 |
| Today’s open | 0.31 |
| Day’s range | 0.29 - 0.31 |
| Volume | 202,029 |
| Average volume (3 months) | 2,016,176 |
| Market cap | $53.2M |
Data as of 3:21pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | +38.46% |
| Earnings growth (this year) | +65.29% |
| Earnings growth (next 5 years) | +15.80% |
| Revenue growth (last year) | -27.68% |
| P/E ratio | NM |
| Price/Sales | 1.76 |
| Price/Book | 0.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ORTXOrchard Therapeutics... | -0.00 | -1.13% |
| OCXOncoCyte Corp | -0.05 | -10.16% |
| ABEOAbeona Therapeutics ... | -0.06 | -1.85% |
| TXMDTherapeuticsMD Inc | +1.54 | +34.53% |
Data as of 3:16pm ET, 12/08/2022
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $213.6M |
| Annual profit (last year) | -$282.8M |
| Net profit margin | -132.43% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
